Life Science Nation (LSN), whose headquarter is located in Boston, MA, is a global platform. LSN sets up a unique database of early-stage investments in healthcare industry, and cooperates with Venture Valuation, a Swiss-based strategic partner, to market the new database of life science, Biotechgate. Since founded in 2012, LSN has have more than 400 clients in North America, Europe, Asia and Oceania.
1. Launching Life Science Nation Platform
Life Science Nation (LSN) was founded by Dennis Ford who brought the marketing ideas into the field of biological science. LSN’s accelerating growth benefits from the changes in the environment of life science. Gradually separated from large pharmaceutical companies and medical device companies, the core value of technology innovation has entered many startups in the field of life science. LSN has become a part of startups’ fundraising plan. The startups look for investors and strategic cooperators through LSN platform. On the other hand, strategic blueprints for multinational companies must work with life science startups. Many large enterprises collaborate with LSN platform to search for new technologies and service suppliers to explore product market.
2. Redefining Early Stage Investment
Since 2013, LSN has hosted Redefining Early Stage Investments (RESI) Conference to bring early-stage investors and startups together. RESI conference was sponsored by Johnson＆Johnson, WuXi AppTec and other multinational companies and held four times a year in Boston, San Francisco, Toronto and San Diego. Each conference has about 500-800 participants. Representatives of companies can search for suitable investors according to their own technical areas and development stage. They can also make appointments to do one-to-one interviews. During the RESI conference, the proportion of entrepreneurs between investors is close to 1:1. The conference has been regarded as an efficient platform to establish strategic cooperative relationship.
